Jennifer Elizabeth Mason

Works (3)

Updated: July 5th, 2023 15:46

2013 article

Optimizing the simultaneous management of blood pressure and cholesterol for type 2 diabetes patients

Mason, J. E., Denton, B. T., Shah, N. D., & Smith, S. A. (2013, September 25). European Journal of Operational Research.

By: J. Mason n, B. Denton n, N. Shah * & S. Smith*

author keywords: OR in medicine; Markov decision process; Type 2 diabetes; Blood pressure treatment; Cholesterol treatment
topics (OpenAlex): Health Systems, Economic Evaluations, Quality of Life; Blood Pressure and Hypertension Studies; Lipoproteins and Cardiovascular Health
TL;DR: A Markov decision process (MDP) model is presented to determine the optimal timing of blood pressure and cholesterol medications for patients with type 2 diabetes and the trade off between quality-adjusted life years and costs of treatment. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: August 6, 2018

2012 article

A comparison of decision-maker perspectives for optimal cholesterol treatment

Mason, J. E., & Denton, B. T. (2012, August 7). IBM Journal of Research and Development.

By: J. Mason n & B. Denton n

topics (OpenAlex): Health Systems, Economic Evaluations, Quality of Life; Pharmaceutical Economics and Policy; Advanced Causal Inference Techniques
TL;DR: A Markov decision process (MDP) is used to show how decision-maker perspectives can influence medical treatment decisions related to cardiovascular risk management in patients with type 2 diabetes, and an inverse MDP model is formulated to estimate the implied monetary value of a year of life, from the societal perspective, according to current U.S. treatment guidelines. (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: August 6, 2018

2011 article

Optimizing Statin Treatment Decisions for Diabetes Patients in the Presence of Uncertain Future Adherence

Mason, J. E., England, D. A., Denton, B. T., Smith, S. A., Kurt, M., & Shah, N. D. (2011, April 29). Medical Decision Making.

By: J. Mason n, D. England n, B. Denton, S. Smith n, M. Kurt  n & N. Shah n

author keywords: adherence; diabetes; statins; Markov decision process
MeSH headings : Adult; Decision Making; Diabetes Mellitus, Type 2 / drug therapy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use; Male; Markov Chains; Middle Aged; Patient Compliance; Quality-Adjusted Life Years
topics (OpenAlex): Medication Adherence and Compliance; Pharmaceutical Economics and Policy; Health Systems, Economic Evaluations, Quality of Life
TL;DR: A Markov decision process (MDP) model is used to optimize the treatment decision for patients with type 2 diabetes and determines the optimal time of statin initiation that minimizes expected costs and maximizes expected quality-adjusted life years (QALYs). (via Semantic Scholar)
UN Sustainable Development Goals Color Wheel
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2026) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.